These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 16891207)
41. Basal cell carcinoma of the prostate: a clinicopathologic study of 29 cases. Ali TZ; Epstein JI Am J Surg Pathol; 2007 May; 31(5):697-705. PubMed ID: 17460452 [TBL] [Abstract][Full Text] [Related]
42. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy. Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095 [TBL] [Abstract][Full Text] [Related]
43. Pitfalls and infrequent findings in fine-needle aspiration of the prostate gland. Pérez-Guillermo M; Acosta-Ortega J; García-Solano J Diagn Cytopathol; 2005 Aug; 33(2):126-37. PubMed ID: 16007671 [TBL] [Abstract][Full Text] [Related]
44. Papillary carcinoma of prostatic ductal origin: a cytologic case report with immunohistochemical and quantitative DNA correlation. Howell LP; Teplitz RL Diagn Cytopathol; 1989; 5(2):211-6. PubMed ID: 2673703 [TBL] [Abstract][Full Text] [Related]
45. [Prognosis of prostate cancer with elevated prostatic acid phosphatase]. Saito T; Kitamura Y; Komatsubara S Hinyokika Kiyo; 2006 Mar; 52(3):177-80. PubMed ID: 16617869 [TBL] [Abstract][Full Text] [Related]
46. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms. Basturk O; Zamboni G; Klimstra DS; Capelli P; Andea A; Kamel NS; Adsay NV Am J Surg Pathol; 2007 Mar; 31(3):363-70. PubMed ID: 17325477 [TBL] [Abstract][Full Text] [Related]
47. Inadequacy of prostate-specific antigen doubling time estimates calculated using an ultrasensitive assay of prostate-specific antigen for biochemical failure after radical prostatectomy. Shimizu F; Matsuyama Y; Tominaga T; Ohashi Y; Fujime M Urol Int; 2007; 79(4):356-60. PubMed ID: 18025856 [TBL] [Abstract][Full Text] [Related]
48. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade. Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706 [TBL] [Abstract][Full Text] [Related]
49. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881 [TBL] [Abstract][Full Text] [Related]
50. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status. Abdou AG; Aiad HA; Sultan SM APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993 [TBL] [Abstract][Full Text] [Related]
51. Prostate carcinoma with squamous differentiation: an analysis of 33 cases. Parwani AV; Kronz JD; Genega EM; Gaudin P; Chang S; Epstein JI Am J Surg Pathol; 2004 May; 28(5):651-7. PubMed ID: 15105655 [TBL] [Abstract][Full Text] [Related]
52. Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp. Samaratunga H; Letizia B Pathology; 2007 Oct; 39(5):476-81. PubMed ID: 17886096 [TBL] [Abstract][Full Text] [Related]
53. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median. Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803 [TBL] [Abstract][Full Text] [Related]
54. External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12 months. Ogawa K; Nakamura K; Sasaki T; Onishi H; Koizumi M; Shioyama Y; Araya M; Mukumoto N; Mitsumori M; Teshima T; Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):759-65. PubMed ID: 19327908 [TBL] [Abstract][Full Text] [Related]
55. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases. Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803 [TBL] [Abstract][Full Text] [Related]
56. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database. Scales CD; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL; Freedland SJ; J Urol; 2007 Oct; 178(4 Pt 1):1249-52. PubMed ID: 17698131 [TBL] [Abstract][Full Text] [Related]
57. Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases. Osunkoya AO; Nielsen ME; Epstein JI Am J Surg Pathol; 2008 Mar; 32(3):468-72. PubMed ID: 18300802 [TBL] [Abstract][Full Text] [Related]
58. The impact of prostate-specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate. Sandblom G; Ladjevardi S; Garmo H; Varenhorst E Cancer; 2008 Feb; 112(4):813-9. PubMed ID: 18098207 [TBL] [Abstract][Full Text] [Related]
59. Primary rhabdomyosarcoma of the prostate. Diagnosis by needle biopsy and immunocytochemistry. Yao JC; Wang WC; Tseng HH; Hwang WS Acta Cytol; 1988; 32(4):509-12. PubMed ID: 2456655 [TBL] [Abstract][Full Text] [Related]
60. Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era. Ercole B; Marietti SR; Fine J; Albertsen PC J Urol; 2008 Oct; 180(4):1336-9; discussion 1340-1. PubMed ID: 18707696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]